Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | NAMS | CNTA | ||
| Company | Recursion Pharmaceuticals Inc Cl A | Newamsterdam Pharma Company N.V. | Centessa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.43 | 18.81 | 12.75 | ||
| High | 4.64 | 19.20 | 13.06 | ||
| Low | 4.31 | 18.55 | 12.44 | ||
| Last | 4.56 | 18.88 | 12.51 | ||
| Change | +0.31 | +0.18 | -0.08 | ||
| % Change | +7.29% | +0.96% | -0.64% | ||
| Volume | 22,727,400 | 501,200 | 1,408,500 | ||
| 20-Day Average Volume | 19,121,676 | 666,780 | 614,020 | ||
| Previous Close | 4.25 | 18.70 | 12.59 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.03 | 18.55 | 12.94 | ||
| 20-Day Raw Stochastic | 22.50% | 60.12% | 26.85% | ||
| 20-Day Relative Strength | 42.82% | 49.74% | 44.71% | ||
| Weighted Alpha | -64.10 | -18.55 | +15.46 | ||
| Today's Opinion | 100% Sell | 64% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 64% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 72% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.31% since 05/09/25 | +2.78% since 05/09/25 | +1.71% since 05/09/25 | ||
| Low | 4.12 on 05/15/25 | 18.25 on 05/14/25 | 11.94 on 05/15/25 | ||
| High | 4.75 on 05/13/25 | 19.60 on 05/14/25 | 13.35 on 05/12/25 | ||
| 1-Month | |||||
| %Chg | -14.29% since 04/16/25 | +17.78% since 04/16/25 | +5.75% since 04/16/25 | ||
| Low | 4.11 on 05/07/25 | 15.82 on 04/21/25 | 11.82 on 05/06/25 | ||
| High | 6.11 on 04/23/25 | 20.91 on 05/08/25 | 14.39 on 05/02/25 | ||
| 3-Month | |||||
| %Chg | -56.70% since 02/14/25 | -5.17% since 02/14/25 | -26.71% since 02/14/25 | ||
| Low | 3.79 on 04/09/25 | 14.06 on 04/07/25 | 9.60 on 04/09/25 | ||
| High | 12.36 on 02/18/25 | 24.51 on 03/24/25 | 17.97 on 03/13/25 | ||
| 6-Month | |||||
| %Chg | -26.15% since 11/15/24 | -24.18% since 11/15/24 | -21.81% since 11/15/24 | ||
| Low | 3.79 on 04/09/25 | 14.06 on 04/07/25 | 9.60 on 04/09/25 | ||
| High | 12.36 on 02/18/25 | 27.29 on 12/11/24 | 19.09 on 02/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,853,617 | 2,073,364 | 1,671,311 | ||
| Shares Outstanding, K | 406,495 | 109,818 | 133,598 | ||
| Annual Sales | 58,840,000 | 45,560,000 | 0 | ||
| Annual Net Income | -463,660,000 | -241,600,000 | -235,760,000 | ||
| Last Quarter Sales | 14,750,000 | 2,980,000 | 0 | ||
| Last Quarter Net Income | -202,490,000 | -39,530,000 | -111,330,000 | ||
| 60-Month Beta | 0.99 | 0.01 | 1.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 05/05/25 | -0.49 on 05/08/25 | -0.20 on 05/14/25 | ||
| Latest Earnings Date | 05/05/25 | 05/14/25 | 05/12/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||